Cargando…
Phylogrouping and characterization of Escherichia coli isolated from colonic biopsies and fecal samples of patients with flare of inflammatory bowel disease in Iran
BACKGROUND: Although the etiopathogenesis of inflammatory bowel disease (IBD) is still poorly understood, Escherichia coli has been described as a potential causative microorganism in IBD pathogenesis and also disease progression, offering a potential therapeutic target for disease management. There...
Autores principales: | Nadalian, Banafsheh, Nadalian, Bahareh, Houri, Hamidreza, Shahrokh, Shabnam, Abdehagh, Mohammad, Yadegar, Abbas, Ebrahimipour, Gholamhossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464868/ https://www.ncbi.nlm.nih.gov/pubmed/36106322 http://dx.doi.org/10.3389/fmed.2022.985300 |
Ejemplares similares
-
Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
por: Abdehagh, Mohammad, et al.
Publicado: (2021) -
Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn’s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets
por: Khorsand, Babak, et al.
Publicado: (2022) -
Microcin determinants are associated with B2 phylogroup of human fecal Escherichia coli isolates
por: Micenková, Lenka, et al.
Publicado: (2016) -
Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad, Masoumeh, et al.
Publicado: (2020) -
Intestinal microbiota changes pre- and post-fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection among Iranian patients with concurrent inflammatory bowel disease
por: Gholam-Mostafaei, Fahimeh Sadat, et al.
Publicado: (2023)